Sentinel Lymph Node Technique in Multifocal Breast Cancer

Study acronym: IGASSU
StatusCompleted
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 15 words
    • Site details revised at 1 of 20 sites
    • Study description expanded, about 5 words
  2. Primary and study completion dates: Sep 2008 to Aug 13, 2010v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Recruiting to Completedv2 Show 7 more changesShow less
    • Enrollment target: 203 to 216
    • Study sites: 17 to 20
    • Primary completion date: Sep 2008
    • Study completion date: Mar 2008 to Sep 2008
    • Start date: Feb 2006 to Mar 2006
    • Secondary endpoints: details revised at 2 of 2 entries
    • Study description expanded, about 105 words
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The scope of this trial is to assess the Sentinel Lymph Node Technique in Multifocal Breast Cancer
Trial Details
NCT Number NCT00417495
Lead Sponsor Centre Oscar Lambret
Conditions
(from sponsor)		 Breast Cancer
Related terms Adenocarcinoma, Breast Neoplasms
Enrollment 216 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov